
|Articles|November 15, 2018
Quanticate Sponsors PhD Research into Response-Adaptive Trial Design
Advertisement
Quanticate, a data-focused CRO, has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. The partnership will support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomization.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5






.png)



.png)



.png)
.png)
